News - Rest of the World

Filter

Current filters:

Rest of the World

Popular Filters

1 to 25 of 161 results

Arena Pharma in deal with Teva unit for marketing Belviq in Israel

Arena Pharma in deal with Teva unit for marketing Belviq in Israel

21-07-2014

USA-based Arena Pharmaceuticals has entered into an exclusive marketing and supply agreement for its…

AbicArena PharmaceuticalsBelviqLicensingMetabolicsObesityPharmaceuticalRegulationRest of the WorldTeva Pharmaceutical Industries

Harmonizing drugs standards in West Africa

Harmonizing drugs standards in West Africa

18-07-2014

The recent decision by the heads of National Medicine Regulatory Authorities (NMRA) and West African…

AfricaPharmaceuticalRegulationRest of the World

Cipla links with Hetero for biosimilar Aranesp; M&A in Yemen

30-06-2014

Cipla has collaborated with fellow Indian drugmaker Hetero to launch a biosimilar of the drug darbepoetin…

ActoriseAmgenAranespBiosimilarsCiplaGenericsHeteroIndiaMarkets & MarketingMergers & AcquisitionsOncologyRest of the World

Dubai Investments sells 66% stake in Globalpharma to Sanofi

29-06-2014

Dubai Investments PJSC, the leading investment company listed on the Dubai financial market [DFM], has…

GenericsGlobalpharmaMergers & AcquisitionsRest of the WorldSanofi

Cyprus drugmakers to disclose transfers of value to health care professionals

Cyprus drugmakers to disclose transfers of value to health care professionals

23-06-2014

Pharmaceutical companies in Cyprus will disclose transfers of value to health care professionals, as…

Markets & MarketingPharmaceuticalRegulationRest of the World

uniQure signs up Medison to distribute Glybera in Israel

uniQure signs up Medison to distribute Glybera in Israel

29-05-2014

Netherlands-based human gene therapy firm uniQure has entered an exclusive distribution agreement with…

BiotechnologyGlyberaLicensingMedison PharmaRare diseasesRest of the WorlduniQure

Bureaucratic delays hinder pharma investors in Zimbabwe

27-05-2014

Regulatory bureaucracy in the African state of Zimbabwe is a major deterrent to pharmaceutical investors…

FinancialPharmaceuticalRegulationRest of the World

Recordati finalizes second tranche of Opalia Pharma acquisition

27-05-2014

Following previous announcements about its M&A activity, Italian drugmaker Recordati has now announced…

GenericsMergers & AcquisitionsOpalia PharmaRecordatiRest of the World

GSK confirms further misconduct allegations, now in Jordan and Lebanon

17-04-2014

There has been recent publicity on cases of alleged misconduct by UK Pharma giant GlaxoSmithKline employees…

GlaxoSmithKlineJordanMarkets & MarketingPharmaceuticalRegulationRest of the World

GlaxoSmithKline targets strategic investments in Africa

02-04-2014

Speaking at the 5th EU-Africa Business Forum in Brussels this week, Sir Andrew Witty, chief executive…

FinancialGlaxoSmithKlineHealthcarePharmaceuticalRest of the WorldSouth Africa

European generic drug makers sets out priorities for EU Trade Policy

European generic drug makers sets out priorities for EU Trade Policy

02-04-2014

European Generic Medicines Association (EGA) revealed this morning that its president, Nick Haggar, has…

EuropeGenericsPoliticsRegulationRest of the World

Call for South African govt to ensure affordable medicines for all

03-03-2014

South Africa’s National Education, Health and Allied Workers' Union (NEHAWU) has reiterated its position,…

Patents & Trade marksPharmaceuticalPoliticsPricingRest of the WorldSouth Africa

Recordati gains certain rights to Apricus’ Vitaros

10-02-2014

Italian drugmaker Recordati has signed an exclusive license agreement with the USA’s Apricus Biosciences…

Apricus BioscienceEastern EuropeLicensingMen's HealthPharmaceuticalRecordatiRest of the WorldTurkeyVitaros

Adcock Ingram and CFR Pharma call off merger

Adcock Ingram and CFR Pharma call off merger

10-02-2014

South Africa’s Adcock Ingram and Chile’s largest drugmaker CFR Pharmaceuticals have issued a joint…

Adcock IngramBidvestCFR PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the WorldSouth Africa

South African R&D-based pharma industry group says it has rejected campaign against patent reform

20-01-2014

The Innovative Pharmaceutical Association South Africa An association (IPASA), a trade group of R&D-based…

PatentsPharmaceuticalRest of the WorldSouth Africa

Nigerian activists move to stop supply of sub-standard HIV/AIDS drugs

03-01-2014

Treatment Action Movement (TAM), a coalition of HIV treatment activists in Nigeria, in collaboration…

Anti-viralsPharmaceuticalRegulationRest of the WorldTYONEXTyonex Nigeria

Report: Egypt’s pharma spending up 12% in 2013 and predicted to keep rising

28-12-2013

Political turmoil is having a mixed impact on Egypt’s pharmaceutical and health care sector, according…

Markets & MarketingPharmaceuticalPoliticsRest of the World

Takeda sets sights on Israeli pharma market, with new subsidiary

Takeda sets sights on Israeli pharma market, with new subsidiary

18-12-2013

Through a European subsidiary, Japan’s largest drugmaker Takeda Pharmaceuticals today announced further…

ManagementMarkets & MarketingPharmaceuticalRest of the WorldTakeda Pharmaceuticals

CFR Pharma increases bid for Adcock Ingram which is still rejected by PIC

CFR Pharma increases bid for Adcock Ingram which is still rejected by PIC

16-12-2013

Chilean drugmaker CFR Pharmaceuticals has raised its offer price for Adcock Ingram, South Africa’s…

Adcock IngramBidvestMergers & AcquisitionsPharmaceuticalRest of the World

Sanofi to commercialize Vivus ED drug in Africa, Middle East, Turkey and CIS/Russia

Sanofi to commercialize Vivus ED drug in Africa, Middle East, Turkey and CIS/Russia

12-12-2013

US drugmaker Vivus has entered into a license and commercialization agreement with French pharma major…

avanafilEastern EuropeLicensingMarkets & MarketingMen's HealthPharmaceuticalRest of the WorldSanofiVivus

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

FT Pharma 2013: Teva’s acting CEO says it has “a very strong and clear strategy”

05-12-2013

Eyal Desheh, acting president and chief executive of the world’s largest generics maker Teva (NYSE:…

CopaxoneGenericsInterviewsManagementPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

African experts discuss need for better regulation of medicine

05-12-2013

In most African countries, pharmaceutical drugs are poorly regulated or not regulated at all, posing…

PharmaceuticalRegulationRest of the World

Bidvest aims to acquire 34.5% stake in South Africa’s Adcock Ingram, to thwart CFR bid

Bidvest aims to acquire 34.5% stake in South Africa’s Adcock Ingram, to thwart CFR bid

03-12-2013

South African conglomerate Bidvest, acting on behalf of a consortium including CIH, says it has offered…

Adcock IngramBiovest InternationalCFR PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the WorldSouth Africa

1 to 25 of 161 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top